Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....
Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....
Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....
Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....
AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....
Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....
Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....
Amgen Inc. (AMGN), a leading biotechnology company, has recently reported strong earnings, surpassing market expectations....
Amgen Inc. (NASDAQ: AMGN) has been making waves in the pharmaceutical industry with its breakthrough drugs and innovative research....
Amgen Inc (AMGN) recently held its Q4 2024 earnings call, where it highlighted robust revenue growth and strategic expansions. The company reported revenue surpassing estimates, reaching $9....
GlaxoSmithKline, commonly known as GSK, a leading global pharmaceutical company, has recently made significant progress in its pipeline plans by developing a breakthrough treatment for a life-threatening disease. The company's innovative research and development efforts have paid off, leading to the creation of a promising drug that could potentially revolutionize the healthcare industry. GSK's br...
AstraZeneca PLC, a leading global pharmaceutical company, has reported a significant breakthrough in its cancer treatment research....
Pfizer Inc., the renowned pharmaceutical company, has made a groundbreaking discovery in the fight against COVID-19....
Bristol-Myers Squibb Company (BMY) recently awarded a milestone payment of $25 million for the discovery of a breakthrough treatment target for ALS (Amyotrophic lateral sclerosis), also known as Lou Gehrig's disease. The significant achievement was made possible through a collaboration with insitro, a leading precision medicine company. The selection of the first novel genetic target marks a major...
GSK PLC's antibody-drug conjugate (ADC) has recently been granted the breakthrough therapy designation by the US Food and Drug Administration (FDA)....